Innovate Corp

This advisory proposal asks stockholders to approve, on a non-binding basis, the compensation paid to INNOVATE’s named executive officers as disclosed in the proxy statement. Management seeks this advisory approval to confirm stockholder support for its pay philosophy, which emphasizes performance-based compensation, retention of key executives, and alignment of executives’ interests with stockholders through equity awards. The Company describes a compensation mix that includes base salary, cash bonuses tied to performance metrics, and equity awards (RSAs/RSUs and options) designed to link pay to both short-term and long-term results; the proxy discloses significant equity grants to the Interim CEO and bonuses for the CFO tied to corporate and individual goals. The advisory vote is non-binding but important: the Board and Compensation Committee intend to consider the vote results when setting future compensation. Contextually, the Company faced refinancing transactions in 2025 and reports mixed financial performance (significant operating developments in segments but net losses), which bears on judgments about executive incentives and retention. The Board recommends FOR because it believes the program balances incentive alignment and retention needs while incorporating governance safeguards (minimum vesting, clawback/forfeiture provisions, and no liberal recycling). The proposal’s non-binding nature means it will not change past payments but will inform future pay practices; institutional investors typically weigh such votes as a signal of governance health. Given the disclosed equity usage and the Company’s burn and overhang metrics, shareholders approving this advisory item would indicate support for the Compensation Committee’s approach to incentivizing management through equity and cash mix. In evaluating the merits, a sophisticated analyst should weigh the Company’s explicit rationale for the awards (including contractually mandated grants under the Interim CEO’s employment agreement), historical pay-versus-performance metrics presented in the proxy, and whether the governance protections adequately mitigate potential misalignment or excessive dilution.

This management proposal requests shareholder approval to increase the authorized share reserve under the Second A&R 2014 Omnibus Equity Award Plan from 1,300,000 to 2,100,000 shares. Management seeks this approval because the Company needs additional shares to continue making equity grants used for retention, recruitment, and long-term incentive alignment, including contractual and recurring grants (for example, option grants to the Interim CEO under his employment agreement). The proxy provides detailed governance protections associated with the plan—including a one-year minimum vesting requirement, double-trigger vesting on change in control where replacement awards are issued, prohibition on paying dividends on unvested awards, a prohibition on repricing options or SARs without shareholder approval, and absence of an evergreen provision—to mitigate potential stockholder concerns about dilution and poor incentive design. The Company discloses burn rates (historical annual grant usage) and overhang metrics and projects that approving the amendment would result in an overhang of about 6.0% based on recent share counts, which the Board argues is not excessively dilutive. The Compensation Committee and the Board evaluated alternatives and concluded that an increase in the reserve is necessary to maintain competitive equity programs without unduly increasing dilution, particularly given ongoing strategic priorities and the need to incentivize management across multiple operating segments. The proposal is material for investors because it directly affects potential dilution, the availability of equity for future compensation, and the Company’s ability to fulfill contractual grant obligations; a sophisticated analyst should weigh the proposed increase against historical grant pacing, the Company’s equity utilization metrics, and the specifics of planned grants (including annual director grants and the scheduled option grants to the Interim CEO). The Board’s unanimous recommendation for approval is grounded in the view that the plan’s design and guardrails balance employee incentives with stockholder protection, while enabling the Company to pursue its strategic plan. Investors should also consider the Company’s recent financial context—refinancing transactions, segment performance, and net loss trends—when assessing whether further equity issuance is consistent with long-term value creation.